Lifevantage Corporation Common Stock (Delaware)
LFVNLifeVantage Corporation (LFVN) is a biotech company specializing in the development and distribution of dietary supplements and skincare products. It focuses on leveraging scientific research to create products that support health, wellness, and anti-aging. The company operates through a network marketing model, emphasizing the promotion of its products via independent distributors.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 15, 2026 | $0.05 | 2026-06-01 | 2026-06-01 |
| March 16, 2026 | $0.04 | 2026-03-02 | 2026-03-02 |
| December 15, 2025 | $0.04 | 2025-12-01 | 2025-12-01 |
| September 16, 2025 | $0.04 | 2025-09-08 | 2025-09-08 |
| June 13, 2025 | $0.04 | 2025-05-30 | 2025-05-30 |
Dividends Summary
- Consistent Payer: Lifevantage Corporation Common Stock (Delaware) has rewarded shareholders with 18 dividend payments over the past 4 years.
- Total Returned Value: Investors who held LFVN shares during this period received a total of $1.05 per share in dividend income.
- Latest Payout: The most recent dividend of $0.05/share was paid 33 days ago, on June 15, 2026.
- Yield & Schedule: LFVN currently pays dividends quarterly with an annual yield of 2.98%.
- Dividend Growth: Since 2022, the dividend payout has grown by 66.7%, from $0.03 to $0.05.
- Dividend Reliability: LFVN has maintained or increased its dividend for 11 consecutive payments.
Company News
LifeVantage Corporation (NASDAQ: LFVN) announced that its Board of Directors has approved a quarterly cash dividend of $0.050 per share, payable on June 15, 2026 to shareholders of record as of June 1, 2026. The company is a health and wellness firm specializing in nutrigenomics and cellular activation products.
LifeVantage Corporation (NASDAQ: LFVN) announced that its Board of Directors approved a quarterly cash dividend of $0.045 per share, payable on March 16, 2026 to shareholders of record as of March 2, 2026. The company is a health and wellness firm specializing in nutrigenomics and activation products.
LifeVantage Corporation announced a quarterly cash dividend of $0.045 per share, payable on December 15, 2025, to stockholders of record as of December 1, 2025.
LifeVantage reported Q1 fiscal 2026 revenue of $47.6 million, a slight 0.7% increase from the previous year. The company highlighted its strategic acquisition of LoveBiome and saw modest growth in the Americas and Asia/Pacific & Europe regions.
LifeVantage Corporation has completed its acquisition of LoveBiome, a direct sales company focused on microbiome care and wellness solutions. The strategic transaction expands LifeVantage's product portfolio into the gut health market and broadens its reach in the US, Taiwan, and Europe.
